Furthermore, PI3K/AKT activation, Cdc42 (Cell Division Cycle 42) protein production, and proteasome-mediated degradation are all mechanisms by which luteolin inhibits GBM cell migration [263,264,265]. The gene discussed is AKT1; the disease is glioblastoma.